Part of the Hidradenitis Suppurativa Knowledge Library
This is the part of HS that gets typed into a search bar rather than said out loud in a consulting room. Patients rarely raise it, and clinicians rarely ask, so it goes unaddressed for years while quietly being one of the heaviest costs of the disease.
We are going to be plain about it, because the silence is doing damage on its own.
Disease at the groin, inner thigh, buttock or under the breast sits exactly where privacy lives. Talking about it means describing a site you have spent years not describing. Most people conclude, reasonably, that a fifteen-minute dermatology appointment is not the place.
So it does not come up. And because it does not come up, patients assume they are unusual in struggling with it. They are not. Where the disease sits, this follows.
It is worth saying directly: shame is a symptom of the site, not a flaw in you. A lesion in the armpit produces inconvenience. The same lesion in the groin produces silence. That difference is about anatomy and social meaning, not about character.
The withdrawal is usually gradual and rarely announced. It tends to look like declining situations rather than refusing them — being tired, being busy, being somewhere else.
What patients describe stopping: undressing with the light on, or at all. Being touched near the affected site, then near it at all. Swimming, shared changing rooms, overnight stays. Starting anything new, because a new relationship means an explanation they have no script for. Some stop initiating and let a partner conclude the interest has gone, which is a misunderstanding that then does its own damage.
The common thread is not usually pain, though pain matters. It is anticipated judgement — the expectation of a reaction that in most cases has not happened yet.
Groin HS is routinely mistaken for a sexually transmitted infection. Patients get swabbed, sometimes repeatedly, sometimes with the assumption stated out loud. Every result comes back clean.
The clinical cost is delay — months or years before anyone says the word hidradenitis. The personal cost is larger and less discussed. Being investigated for an STI you do not have, in front of a partner, attaches a suspicion to a disease that has nothing to do with transmission.
So, unambiguously: HS is not sexually transmitted. It is not an infection you caught, and it is not something you can pass to a partner. It is an inflammatory disease of the follicle and the surrounding tissue. If that has been implied to you, it was wrong, and it is worth saying so to anyone it was implied to.
There is no script that fits every relationship, but a few things hold generally.
Earlier is usually easier than later. The longer concealment runs, the more the disclosure feels like a confession rather than information — and the more a partner has had to invent explanations for the distance.
Say what it is before what it looks like. "I have an inflammatory skin condition that affects this area, it is not contagious, and it flares" gives a partner the frame they need. Most reactions people fear are reactions to confusion, not to the disease.
You are allowed to set the terms. Which sites are off-limits during a flare, what you do and do not want looked at, what help you want and what you do not — those are yours to decide and reasonable to state.
A partner who reacts badly to accurate information about a medical condition has told you something useful. That is not a failure of your disclosure.
Practical rather than restrictive:
None of this is a rule about what you should or should not do. It is the same barrier, friction and moisture logic that applies to the disease everywhere else.
What treatment works on is the inflammatory load, and with it drainage, pain and flare frequency. Those are the three things that actually decide whether closeness is possible in a given week, so as they change, this changes.
Confidence usually lags the disease. Patients whose lesions have settled often keep the avoidance habits for a while afterwards — the caution was learned over years and does not switch off because a marker improved. That is expected, and worth naming rather than treating as a relapse.
What treatment does not change is scarring. Established tunnels and dense fibrosis are structural; internal treatment can quiet the inflammation around them but does not dissolve them. If part of what you are managing is how the area looks rather than how it behaves, that part does not resolve, and we would rather say so than let you wait for it.
Some patients have withdrawn from the possibility of a relationship entirely, and have been there long enough that it no longer feels like a decision.
What we would say is this. HS can affect confidence, intimacy and relationships. It does not determine what you are worth. Most people who withdraw are protecting themselves against judgement they anticipate rather than judgement they have met — and the fear of it is frequently heavier than the thing itself. As symptoms improve, confidence commonly follows, though usually more slowly than the skin.
Alongside medical treatment we would encourage open communication with a partner you trust, and we would say plainly that you deserve a healthy relationship as much as anyone else does. If this is the part of the disease weighing most heavily, it is worth raising — with us, or with someone qualified to help with it. It is a legitimate part of the condition, not a separate personal failing you are expected to handle alone.
And for what it is worth: you will not be asked to undress in front of anyone here.
